PDL BioPharma, Inc. Share Repurchase Authorization
PDL BioPharma, Inc. had Share Repurchase Authorization of $275.00 million as of 2019-12-31, per its 10-Q filed 2020-05-11.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2021-03-29
- 2019-12-31: Stock Repurchase Program, Authorized Amount $275.00M.
- 2019-12-16: Stock Repurchase Program, Authorized Amount $75.00M.
- 2019-12-09: Stock Repurchase Program, Authorized Amount $200.00M.
- 2018-09-24: Stock Repurchase Program, Authorized Amount $100.00M.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2019-12-31 | $275.00M 10-Q · filed 2020-05-11 |
| 2019-12-16 | $75.00M 10-K · filed 2021-03-29 |
| 2019-12-09 | $200.00M 10-K · filed 2021-03-29 |
| 2018-09-24 | $100.00M 10-K · filed 2021-03-29 |
| 2018-09-21 | $100.00M 10-Q · filed 2020-11-13 |
| 2017-09-25 | $25.00M 10-K · filed 2021-03-29 |
| 2017-06-30 | $30.00M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $30.00M 10-Q · filed 2017-05-03 |
| 2017-03-02 | $30.00M 10-K · filed 2021-03-29 |